DEPTOR/DEPDC6 antibody | knockout validation | Cell Signaling 11816

This is a knockout-validated antibody summary, based on the publication "DEPTOR Is an in Vivo Tumor Suppressor That Inhibits Prostate Tumorigenesis via the Inactivation of mTORC1/2 Signals", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

DEPTOR/DEPDC6 antibody | knockout validation | Cell Signaling 11816 figure 1
Figure 1. DU145 cells were treated with various doses of Torin-1 for 12 h and then harvested for Western blotting using the indicated antibodies. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: DEPTOR/DEPDC6

Catalog number: 11816

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to residues surrounding Leu113 of human DEPTOR/DEPDC6 protein. Reacts with human, rat and monkey. Suitable for western blot, immunoprecipitation and immunohistochemistry (paraffin).

Validation Method

Western blot

Sample

Control and DEPTOR-KO DU145 cells. Cells were lysed in lysis buffer with protease inhibitors and phosphatase inhibitors.

References
  1. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher